How federated analytics enables decision-ready evidence in pharma
Discover how federated analytics helps pharma generate trusted, decision-ready evidence while enabling scalable, privacy-preserving research.
Resources and expert insights
Check out the latest thinking from our team — explore our blog, read white papers, watch videos, and more.
Viewing results for:
Filter by type
Filter by topic
Search
Read more
What’s next for clinical trials? Exploring the rise of personalized research
From AI readiness to federated data networks, Mukhtar Ahmed discusses the trends shaping evidence generation and the rise of personalized research.
Building a reusable evidence foundation for confident decision-making
Move beyond one-off studies with a reusable evidence foundation designed for trusted, decision-ready evidence.
From data access to evidence readiness
More data is not enough. Evidence readiness requires connected data, governance, analytics, and scalable foundations.
Beyond build vs. buy: choosing a trusted research environment that scales
A framework for balancing control, governance, federation, and sustainability in trusted research environments.
How federated analytics turns distributed data into trusted evidence
Turn distributed data into trusted evidence with federated analytics that supports decision-making across the product lifecycle.
Building the future of evidence generation
More data does not create better evidence. Decision-ready evidence starts with the right data, analytics, and governance.
Advancing safer pediatric medicine through trusted genomic research
How trusted genomic research and clinical data support safer pediatric treatment decisions and precision medicine.
From more data to better decisions: Building reusable evidence foundations
Fit-for-purpose data, governance, and federated analytics help life sciences teams build reusable evidence foundations.